EA200101171A1 - Способ лечения инфекций, вызванных streptococcus pneumoniae - Google Patents

Способ лечения инфекций, вызванных streptococcus pneumoniae

Info

Publication number
EA200101171A1
EA200101171A1 EA200101171A EA200101171A EA200101171A1 EA 200101171 A1 EA200101171 A1 EA 200101171A1 EA 200101171 A EA200101171 A EA 200101171A EA 200101171 A EA200101171 A EA 200101171A EA 200101171 A1 EA200101171 A1 EA 200101171A1
Authority
EA
Eurasian Patent Office
Prior art keywords
caused
streptococcus pneumoniae
treating infections
susceptible
teicoplanin
Prior art date
Application number
EA200101171A
Other languages
English (en)
Other versions
EA004295B1 (ru
Inventor
Томас Ривз Парр
Маргарет Мэри Василевски
Майкл Ли Зекел
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200101171A1 publication Critical patent/EA200101171A1/ru
Publication of EA004295B1 publication Critical patent/EA004295B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Предоставлен способ лечения для длительной профилактики инфекции S.pneumoniae у восприимчивых индивидуумов, посредством которого, по меньшей мере, 1 раз/мес. восприимчивому индивидууму вводится доза N-(4-(4-хлорфенил)бензил)А82846В, тейкопланина, или их смеси.Отчет о международном поиске был опубликован 2001.04.12.
EA200101171A 1999-05-03 2000-04-19 Способ лечения инфекций, вызванных streptococcus pneumoniae EA004295B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13225899P 1999-05-03 1999-05-03
PCT/US2000/008737 WO2000066144A2 (en) 1999-05-03 2000-04-19 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections

Publications (2)

Publication Number Publication Date
EA200101171A1 true EA200101171A1 (ru) 2002-04-25
EA004295B1 EA004295B1 (ru) 2004-02-26

Family

ID=22453188

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200101171A EA004295B1 (ru) 1999-05-03 2000-04-19 Способ лечения инфекций, вызванных streptococcus pneumoniae

Country Status (29)

Country Link
EP (1) EP1175222B1 (ru)
JP (1) JP2002543146A (ru)
KR (1) KR100757165B1 (ru)
CN (1) CN1349407A (ru)
AR (1) AR023827A1 (ru)
AT (1) ATE284702T1 (ru)
AU (1) AU774647B2 (ru)
BR (1) BR0010244A (ru)
CA (1) CA2372790A1 (ru)
CZ (1) CZ296127B6 (ru)
DE (1) DE60016734T2 (ru)
DZ (1) DZ3039A1 (ru)
EA (1) EA004295B1 (ru)
HK (1) HK1044707B (ru)
HR (1) HRP20010808A2 (ru)
HU (1) HUP0200940A3 (ru)
IL (2) IL145582A0 (ru)
MY (1) MY123542A (ru)
NO (1) NO20015291L (ru)
NZ (1) NZ514467A (ru)
PE (1) PE20010292A1 (ru)
PL (1) PL353444A1 (ru)
SK (1) SK285970B6 (ru)
SV (1) SV2002000065A (ru)
TR (1) TR200103211T2 (ru)
TW (1) TWI255716B (ru)
UA (1) UA73937C2 (ru)
WO (1) WO2000066144A2 (ru)
ZA (1) ZA200108013B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013202360B2 (en) * 2008-08-30 2016-03-24 Melinta Therapeutics, Inc. Methods of treatment using single doses of oritavancin
CN106620649A (zh) * 2008-08-30 2017-05-10 医药公司 使用单剂量奥利万星的治疗方法
KR102237887B1 (ko) 2013-03-15 2021-04-07 멜린타 서브시디어리 코프. 항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법
LT3038616T (lt) * 2013-08-26 2023-05-25 Melinta Therapeutics, Inc. Bakteriemijos ir osteomielito gydymo būdai naudojant oritavanciną

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
WO2000066144A3 (en) 2001-04-12
NZ514467A (en) 2005-01-28
HK1044707A1 (en) 2002-11-01
AU4329200A (en) 2000-11-17
AU774647B2 (en) 2004-07-01
ATE284702T1 (de) 2005-01-15
SV2002000065A (es) 2002-12-02
WO2000066144A2 (en) 2000-11-09
DE60016734D1 (de) 2005-01-20
JP2002543146A (ja) 2002-12-17
EP1175222A2 (en) 2002-01-30
UA73937C2 (en) 2005-10-17
KR20020008173A (ko) 2002-01-29
CN1349407A (zh) 2002-05-15
ZA200108013B (en) 2003-03-26
NO20015291D0 (no) 2001-10-29
IL145582A0 (en) 2002-06-30
HK1044707B (zh) 2005-09-30
EP1175222B1 (en) 2004-12-15
CZ20013949A3 (cs) 2002-07-17
IL145582A (en) 2008-12-29
CA2372790A1 (en) 2000-11-09
SK15572001A3 (sk) 2003-05-02
HRP20010808A2 (en) 2002-12-31
EA004295B1 (ru) 2004-02-26
MY123542A (en) 2006-05-31
HUP0200940A2 (en) 2002-08-28
PL353444A1 (en) 2003-11-17
TR200103211T2 (tr) 2002-02-21
AR023827A1 (es) 2002-09-04
DZ3039A1 (fr) 2004-03-27
SK285970B6 (sk) 2007-12-06
CZ296127B6 (cs) 2006-01-11
DE60016734T2 (de) 2005-12-08
NO20015291L (no) 2001-12-17
KR100757165B1 (ko) 2007-09-07
PE20010292A1 (es) 2001-03-07
BR0010244A (pt) 2002-01-08
TWI255716B (en) 2006-06-01
HUP0200940A3 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
NO20025450D0 (no) Ny farmasöytisk sammensetning
DE50214206D1 (de) Kombinationstherapie substituierter oxazolidinone
BG101118A (en) Therapeutical compounds
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
ATE290548T1 (de) Expressionsblockierung von virulenten faktoren in s. aureus
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
DK261490D0 (da) New pharmaceutical compound
NO20004282D0 (no) Matriksproteinpreparater for sÕrheling
HUP0101817A2 (hu) 15 tagú laktám ketolidok és ezeket tartalmazó antibakteriális hatású gyógyszerkészítmények
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
DK0579681T3 (da) Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse
DE69430385D1 (de) Hiv-proteaseinhibitoren
EA200400530A1 (ru) Перекрестно-сшитые антибиотики "гликопептид-цефалоспорин"
BR0002577A (pt) Suspensões orais de trovafloxacina
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
NO20044549L (no) Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
EA200101171A1 (ru) Способ лечения инфекций, вызванных streptococcus pneumoniae
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
SE0004101D0 (sv) New use
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
NO982863L (no) Nye forbindelser med analgetisk effekt
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης
TR200102009T2 (tr) Serebral işlemi profilaksı ve tedavisi için formül I'e göre bileşiklerin kullanımı

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU